Characteristic |
Phase 1 (n=50) |
Phase 3
(n=50) |
p-value |
Male gender |
50 |
46 |
0.68 |
Age (years, mean ± SD) |
51.9+19.1 |
48.7+18 |
0.98 |
Comorbidities |
Comorbidities |
Comorbidities |
Comorbidities |
Diabetes Mellitus |
30 |
38 |
0.39 |
Hypertension |
34 |
30 |
0.66 |
Asthma |
0 |
2 |
1.00 |
COPD |
14 |
22 |
0.21 |
CKD |
6 |
14 |
0.31 |
CAD |
6 |
18 |
0.12 |
CVA |
2 |
8 |
0.36 |
APACHE II score* |
20.5 + 6.9 |
23.5 + 6.6 |
0.02 |
SOFA score* |
8.1 + 3.2 |
8.2 + 3.2 |
0.90 |